ArticleJCO global oncology2020

Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts.

Dominick Bossé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.